| Issue Date | Title | Author(s) |
| 11-May-2020 | Active SB-P Versus Conventional Approach to the Protection of High -Risk Side Branches The CIT-RESOLVE Trial | Dou, Kefei; Zhang, Dong; Pan, Hongwei; Guo, Ning; Li, Lang; Li, Yue; Zhang, Qi; Liu, Bin; Shen, Zhujun; Zhang, Bin; Liu, Jian; Han, Wei; Wang, Yang; Zhao, Yanyan; Yang, Yuejin; Chen, Shaoliang; Xie, Lihua; Guan, Changdong; Kirtane, Ajay J.; Xu, Bo |
| 2013 | The Association between Atherosclerotic Renal Artery Stenosis and Acute Kidney Injury in Patients Undergoing Cardiac Surgery | Yang, Jingang; Lu, Changlin; Yan, Li; Tang, Xinran; Li, Wei; Yang, Yuejin; Hu, Dayi |
| 2010 | Atherosclerotic Plaque Morphology and Serous Hypersensitive C-Reactive Protein in Patients with Premature Coronary Heart Disease | Gao, Lijian; Xie, Rongai; Chen, Jun; Chen, Jilin; Yang, Yuejin; Bo Xu; Qiao, Shubin; Li, Jianjun; Qian, Jie; Gao, Runlin |
| 2015 | Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease ABSORB China Trial | Gao, Runlin; Yang, Yuejin; Han, Yaling; Huo, Yong; Chen, Jiyan; Yu, Bo; Su, Xi; Li, Lang; Kuo, Hai-Chien; Ying, Shih-Wa; Cheong, Wai-Fung; Zhang, Yunlong; Su, Xiaolu; Xu, Bo; Popma, Jeffery J.; Stone, Gregg W. |
| Sep-2020 | China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial | Xu, Yi; Li, Xiangdong; Zhang, Haitao; Wu, Yuan; Zhang, Jun; Li, Jia; Dou, Kefei; Yan, Hongbing; You, Shijie; Yang, Yanmin; Liang, Yan; Xu, Lianjun; Gao, Xiaojin; Liu, Chen; Dong, Qiuting; Zhang, Wenjia; Song, Guangyuan; Zhang, Tao; Jiang, Lin; Chen, Guihao; Tang, Ruijie; Jin, Chen; Yang, Jingang; Yao, Chen; Xian, Ying; Peterson, Eric D.; Gao, Runlin; Yang, Yuejin |
| 2010 | Chronic Kidney Disease, All-Cause Mortality and Cardiovascular Mortality Among Chinese Patients with Established Cardiovascular Disease | Yang, Jin-gang; Li, Jue; Lu, Changlin; Hasimu, Buaijiaer; Yang, Yuejin; Hu, Dayi |
| 2018 | Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial | Xu, Bo; Yang, Yuejin; Han, Yaling; Huo, Yong; Wang, Lefeng; Qi, Xiangqian; Li, Jifu; Chen, Yundai; Kuo, Hai-Chien; Ying, Shih-Wa; Cheong, Wai-Fung; Zhang, Yunlong; Su, Xiaolu; Popma, Jeffery J.; Gao, Runlin; Stone, Gregg W. |
| 6-Aug-2024 | Development and External Validation of an Artificial Intelligence-Based Method for Scalable Chest Radiograph Diagnosis: A Multi-Country Cross-Sectional Study | Liu, Zeye; Xu, Jing; Yin, Chengliang; Han, Guojing; Che, Yue; Fan, Ge; Li, Xiaofei; Xie, Lixin; Bao, Lei; Peng, Zimin; Wang, Jinduo; Chen, Yan; Zhang, Fengwen; Ouyang, Wenbin; Wang, Shouzheng; Guo, Junwei; Ma, Yanqiu; Meng, Xiangzhi; Fan, Taibing; Zhi, Aihua; Dawaciren; Yi, Kang; You, Tao; Yang, Yuejin; Liu, Jue; Shi, Yi; Huang, Yuan; Pan, Xiangbin |
| 2009 | Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: Results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study | Bi, Yufang; Gao, Runlin; Patel, Anushka; Su, Steve; Gao, Wei; Hu, Dayi; Huang, Dejia; Kong, Lingzhi; Qi, Wenhang; Wu, Yangfeng; Yang, Yuejin; Turnbull, Fiona |
| 2014 | In-hospital death causes of acute myocardial infarction after primary PCI: retrospective analysis from Beijing PCI registry 2010-2013 | Song, Lei; Yang, Yuejin; Lv, Shuzheng; Wang, Lefeng; Gao, Wei; Guo, Jincheng; Hao, Hengjian; Fang, Quan; Wu, Mingying; Li, Hongwei |
| 2012 | Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial | Xu, Bo; Dou, Kefei; Yang, Yuejin; Lv, Shuzheng; Wang, Lefeng; Wang, Haichang; Li, Zhanquan; Wang, Lei; Chen, Yundai; Huo, Yong; Li, Wei; Kirtane, Ajay J.; Gao, Runlin |
| 2012 | NOYA I: A Prospective Randomized Trial of the Biodegradable Polymer NOYA Sirolimus-Eluting Stent Compared with the Durable Polymer FIREBIRD 2 Sirolimus-Eluting Stent in Patients with Coronary Artery Disease: 9-Month Angiographic and 24-Month Clin | Xu, Bo; Dou, Kefei; Yang, Yuejin; Lu, Shuzheng; Wang, Lefeng; Wang, Haichang; Li, Zhanquan; Wang, Lei; Chen, YunDai; Huo, Yong; Kirtane, Ajay; Gao, Run-Lin |
| 2013 | One-year cardiovascular event rates in Chinese patients with atherothrombotic disease | Yang, Jingang; Yang, Yuejin; Gu, Hongqiu; Li, Wei; Hu, Dayi |
| Aug-2023 | Pleiotropic activities of succinate: The interplay between gut microbiota and cardiovascular diseases | Xu, Jing; Yang, Yicheng; Li, Xin; Ding, Shusi; Zheng, Lemin; Xiong, Changming; Yang, Yuejin |
| 2024 | Promising dawn in the management of pulmonary hypertension: The mystery veil of gut microbiota | Yang, Yicheng; Zhang, Hanwen; Wang, Yaoyao; Xu, Jing; Shu, Songren; Wang, Peizhi; Ding, Shusi; Huang, Yuan; Zheng, Lemin; Yang, Yuejin; Xiong, Changming |
| 2017 | A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study | Han, Yaling; Liu, Haiwei; Yang, Yuejin; Zhang, Jian; Xu, Kai; Fu, Guosheng; Su, Xi; Jiang, Tiemin; Pang, Wenyue; Chen, Jiyan; Yuan, Zuyi; Li, Hui; Wang, Haichang; Hong, Tao; Liu, Huiliang; Sun, Fucheng; Allocco, Dominic J.; Zhang, Mingdong; Dawkins, Keith D. |
| 2013 | Safety and Efficacy of a Novel Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Lesions: 12-Month Results from the Prospectively Patient-Level Pooled Analysis of the TARGET I and TARGET I | Gao, Run-Lin; Xu, Bo; Lansky, Alexandra; Yang, Yuejin; Zhang, Ruiyan; Ma Changsheng; Li, Hui; Chen, Shao Liang; Han, Yaling; Yuan, Zuyi; Huo, Yong; Li, Wei; Zhao, Yelin; Leon, Martin |
| 2014 | Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 2-year results from the prospectively patient-level pooled analysis of the TARGET I and TARGET II | Zhao, Yelin; Xu, Bo; Yang, Yuejin; Huo, Yong; Lansky, Alexandra; Leon, Martin; Guan, Changdong |
| 2013 | Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Coronary Artery Lesions: The TARGET I Trial | Xu, Bo; Gao, Run-Lin; Lansky, Alexandra; Yang, Yuejin; Ma Changsheng; Han, Yaling; Chen, Shao Liang; Li, Hui; Zhang, Ruiyan; Fu, Guosheng; Yuan, Zuyi; Huo, Yong; Li, Wei; Zhao, Yelin; Leon, Martin |
